A multi-layered wound dressing including a fibrous absorbent layer for absorbing exudate from a wound site. The wound dressing also includes a support layer configured to reduce shrinkage of at least a portion of the wound dressing.

A catheter for transcutaneous and transluminal vacuum closure of perianal or entero-cutaneous fistulas and abscesses containing a body ending in a dome having a low-friction surface and equipped with a series of openings on the surface that connect inside the catheter body into a catheter chamber, which is then connected to a tube connected to a vacuum generating system characterized in that the catheter body on the outside has edges arranged in the shape of many helicoid coils, and in the grooves between these coils the series of openings are made into the chamber inside the catheter.

The wound therapy apparatus may include a wound interface sealingly securable to the skin surface around a wound bed to encloses the wound bed within an enclosed space that is fluid-tight. The wound interface may be sufficiently deformation resistant to distend at least a portion of the wound bed into the enclosed space when pressure p.sub.0 within the enclosed space is less than ambient pressure p.sub.amb. Fluid may be communicated with the enclosed space when the wound interface is sealingly secured to the skin surface in order to vary a pressure p.sub.0 within the enclosed space periodically over the pressure range p.sub.min≤p.sub.0≤p.sub.max. The variation of the pressure p.sub.0 may distend the wound bed into communication with a pad received within the enclosed space and decreases the wound bed contact with the pad. Related methods of use of the wound therapy apparatus are also disclosed.

In some embodiments, a negative pressure wound therapy device includes a negative pressure source and a controller configured to, in response to determining that the negative pressure source is directly fluidically connected to a wound dressing without a canister between the two, operate the negative pressure source in a first mode; otherwise, operate the negative pressure source in a second, different mode. The controller can be further configured to, in response to determining that a level of activity of the negative pressure source over a first time duration satisfies at least one of a leak or blockage condition, provide an indication of at least one of a leak or blockage and, in response to determining that the level of activity does not satisfy the at least one of the leak or blockage condition over a second time duration subsequent to the first time duration, discontinue providing the indication.

A method and apparatus are disclosed for determining status of a canister of a topical negative pressure (TNP) system. The method includes the steps of monitoring pressure provided by a pump element of the TNP system, determining at least one characteristic associated with the monitored pressure and determining status of at least one parameter associated with a canister of the TNP system responsive to the determined characteristics.

A method of analyzing fluid collected from a wound site, the method comprising the steps of: (a) providing a pump unit comprising: one or more pumps, one or more fluid collectors, and one or more drainage structures each in communication with an exit site of the wound site to draw the fluid through the one or more drainage structures into the pump unit and create a negative pressure at the exit site to remove and transport the fluid from the exit site and into the one or more fluid collectors, wherein the pump unit is configured to create a negative pressure, wherein the fluid removal from the exit site is provided at a controlled and measured rate; b) collecting the fluid within the one or more fluid collectors; c) removing the one or more fluid collectors; e) capping the one or more fluid collectors with a cap; and d) analyzing the collected fluid of step “b” once the fluid connectors are removed in step “c”.

The present disclosure generally relates to a negative wound therapy (NPWT) system (100) comprising a mobile negative pressure device (101), a tubing assembly (105) and a non-absorbent or an absorbent dressing (104).

Disclosed embodiments relate to apparatuses and methods for wound treatment. In certain embodiments, a negative pressure wound therapy apparatus can include a wound dressing comprising an absorbent layer comprising a plurality of portions of absorbent material that can be physically separate from each other. In some embodiments, a wound treatment apparatus can include an absorbent layer comprising a compressed portion configured to impede the flow of fluid therethrough. In some embodiments, a wound treatment apparatus can include an absorbent layer and spacer layer positioned side by side.

A negative pressure wound therapy device includes a piezoelectric pump, a state detector configured to detect a state of the pump, and a control circuit configured to transmit a first control signal for a first period having a first RMS voltage greater than or equal to a threshold voltage at which driving the pump for a second period greater than the first period can cause the pump to emit sound at a magnitude greater than a sound threshold; receive a first indication of the state; determine if the pump is in a leak condition; transmit, responsive to the pump not being in the leak condition, a second control signal having a second RMS voltage less than the first RMS voltage; and transmit, responsive to the pump being in the leak condition, a third control signal having a third RMS voltage greater than the second RMS voltage.

Systems, and methods relate to a medical device receiving a treatment parameter operating point within a first operating region defined by a first set of operating points for which automatic incremental adjustment of a parameter in the current operation is permitted. In an illustrative example, incremental adjustment may use artificial intelligence based on patient feedback and sensor measurement of outcomes. Some exemplary devices may receive a request to alter the current treatment parameter operating point to a second treatment parameter operating point outside the first operating region and in a second operating region in a known safe operation zone, bounded by a known unsafe zone unavailable to the user. In the second operating region, some examples may restrict the step size of incremental adjustments requested by the user. Data may be collected for cloud-based analysis, for example, to facilitate discovery of more effective treatment protocols.